Finance

Lists
STAR:NSE
Strides Pharma Science Ltd
₹978.10
-0.81%
(-8.00) 1D
ኖቬም 17, 3:30:02 ከሰዓት ጂ ኤም ቲ+530  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for STAR...
Open
₹980.50
High
₹1,000.00
Low
₹973.00
Mkt. cap
90.16 ቢ
Avg. vol.
354.46 ሺ
Volume
238.82 ሺ
Dividend
0.51%
Quarterly dividend
₹1.25
Ex-dividend date
31 ጁላይ 2026
P/E ratio
14.62
52-wk high
₹1,260.90
52-wk low
₹768.65
EPS
₹66.90
Shares outstanding
89.55 ሚ
No. of employees
4 ሺ
Open
₹980.50
High
₹1,000.00
Low
₹973.00
Mkt. cap
90.16 ቢ
Avg. vol.
354.46 ሺ
Volume
238.82 ሺ
Dividend
0.51%
Quarterly dividend
₹1.25
Ex-dividend date
31 ጁላይ 2026
P/E ratio
14.62
52-wk high
₹1,260.90
52-wk low
₹768.65
EPS
₹66.90
Shares outstanding
89.55 ሚ
No. of employees
4 ሺ
News stories
From web sources and news partners
Profile
Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. The company partners with generic companies to supply retail and hospital generics in injectable products and softgels. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India. Strides Arcolab changed name to Strides Shasun Ltd after an amalgamation of Shasun Pharmaceuticals with Strides Arcolab. In September 2014, the Board of Directors of both the companies had approved a scheme of amalgamation between the two companies. Arun Kumar is the founder and chairman, and has been on the board as managing director since its inception. Wikipedia
About Strides Pharma Science Ltd
CEO-
Employees3.54 ሺ
Founded1990
Headquartersበንጋሉሩ, ካራናታካ, ህንድ
SectorHealth Care
IndustryPharmaceutical industry
Last report
30 ኦክቶ 2026
Fiscal period
Q2 2027
- / -
Revenue / Est. (INR)
14.30 ቢ / 14.15 ቢ
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
ዲሴም 2025
ማርች 2026
ጁን 2026
ሴፕቴ 2026
Revenue
11.95 ቢ
13.23 ቢ
12.65 ቢ
14.30 ቢ
Cost of goods sold
4.63 ቢ
7.19 ቢ
4.95 ቢ
6.29 ቢ
Cost of revenue
4.63 ቢ
7.19 ቢ
4.95 ቢ
6.29 ቢ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.30 ቢ
3.45 ቢ
2.43 ቢ
2.38 ቢ
Operating expense
5.46 ቢ
4.91 ቢ
5.97 ቢ
6.07 ቢ
Total operating expenses
10.09 ቢ
12.10 ቢ
10.92 ቢ
12.36 ቢ
Operating income
1.85 ቢ
1.13 ቢ
1.73 ቢ
1.94 ቢ
Other non operating income
1.07 ቢ
-1.66 ቢ
48.90 ሚ
40.83 ሚ
EBT including unusual items
2.45 ቢ
1.48 ቢ
2.00 ቢ
1.50 ቢ
EBT excluding unusual items
2.49 ቢ
502.07 ሚ
1.36 ቢ
1.52 ቢ
Income tax expense
373.53 ሚ
187.70 ሚ
341.23 ሚ
163.18 ሚ
Effective tax rate
15.22%
12.68%
17.09%
10.85%
Other operating expenses
2.66 ቢ
928.53 ሚ
2.97 ቢ
3.11 ቢ
Net income
2.02 ቢ
1.27 ቢ
1.57 ቢ
1.31 ቢ
Net profit margin
16.92%
9.59%
12.40%
9.15%
Earnings per share
-
-
-
-
Interest and investment income
-
404.82 ሚ
-
-
Interest expense
-433.79 ሚ
-130.82 ሚ
-405.61 ሚ
-465.41 ሚ
Net interest expenses
-433.79 ሚ
274.00 ሚ
-405.61 ሚ
-465.41 ሚ
Depreciation and amortization charges
506.23 ሚ
532.49 ሚ
563.99 ሚ
572.15 ሚ
EBITDA
2.25 ቢ
1.55 ቢ
2.15 ቢ
2.51 ቢ
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google መተግበሪያዎች